Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06941922

Testicular Evaluation of Azoospermia Using Micro-Ultrasound

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Paul Shin · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigation is a small feasibility study to determine whether there are imaging features related to the seminiferous tubules in the testes under microultrasound. The results from this study will provide guidance on the design and power analysis of future studies in this area.

Detailed description

Currently available ultrasound (US) technology is approximately 12 MHz and offers enough resolution to determine the presence of a tumor or varicocele, but has no real predictive value in terms of imaging robust seminiferous tubules. MicroUS offers significantly higher resolution - down to 70 microns. The average width of a normal seminiferous tubule is 200-250 microns. (Amer 1837). The average width of an atrophic SCO tubule is 75 microns. This echotexture difference cannot be visualized by a conventional ultrasound scan but should, in theory, be detected by a higher resolution (higher MHz) microUS scan. This is a feasibility study to image 40 azoospermic or healthy controls in order to determine whether microultrasound (microUS) images can visualize differences within the testes of these subjects which may be useful in diagnosing the cause of azoospermia and regional differences within the testes where sperm retrieval may be more effective. Specifically, in men with obstructive azoospermia we expect to visualize normal seminiferous tubules while in men with non-obstructive azoospermia we expect to visualize both normal and atrophic seminiferous tubules. The normal tubules in cases of obstructive azoospermia will act as a control by providing an example of normal imaging within a closely related population. Localization of normal tubules within the NOA (non-obstructive azoospermia) population may simplify the microTESE procedure by reducing the amount of dissection required. Additionally, the ability to predict the success of the procedure (i.e. presence of normal tubules) would improve risk/benefit decision-making for men considering it.

Conditions

Timeline

Start date
2025-05-01
Primary completion
2025-10-31
Completion
2025-12-31
First posted
2025-04-24
Last updated
2025-07-11

Locations

2 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT06941922. Inclusion in this directory is not an endorsement.